Inventor
MAGNIN DAVID R
US27 patents
⚠️ This page may combine multiple inventors who share the name “MAGNIN DAVID R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
16 patentsUS6548529B1Apr 15, 2003
Heterocyclic containing biphenyl aP2 inhibitors and method
BRISTOL MYERS SQUIBB CO273 citations99
US6395767B2May 28, 2002
Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
BRISTOL MYERS SQUIBB CO398 citations99
US5739135AApr 14, 1998
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO297 citations99
US5712279AJan 27, 1998
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO319 citations99
US6995183B2Feb 7, 2006
Adamantylglycine-based inhibitors of dipeptidyl peptidase IV and methods
BRISTOL MYERS SQUIBB CO115 citations95
US5312814AMay 17, 1994
α-phosphonocarboxylate squalene synthetase inhibitors
BRISTOL MYERS SQUIBB CO42 citations93
US6472414B1Oct 29, 2002
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO42 citations92
US6066650AMay 23, 2000
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO26 citations92
US5883099AMar 16, 1999
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO29 citations92
US7420079B2Sep 2, 2008
Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereof
BRISTOL MYERS SQUIBB CO26 citations89
US6995180B2Feb 7, 2006
Glycinenitrile-based inhibitors of dipeptidyl peptidase IV and methods
BRISTOL MYERS SQUIBB CO16 citations84
US6927227B2Aug 9, 2005
Heterocyclic containing biphenyl aP2 inhibitors and method
BRISTOL MYERS SQUIBB CO7 citations74
US5470845ANov 28, 1995
Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia
BRISTOL MYERS SQUIBB CO14 citations74
US6984645B2Jan 10, 2006
Dual inhibitors of adipocyte fatty acid binding protein and keratinocyte fatty acid binding protein
BRISTOL MYERS SQUIBB CO8 citations73
US5567841AOct 22, 1996
α-phosphonosulfonate squalene synthetase inhibitors and method
BRISTOL MYERS SQUIBB CO7 citations63
US6034098AMar 7, 2000
Inhibitors of microsomal triglyceride transfer protein and method
BRISTOL MYERS SQUIBB CO3 citations62
SQUIBB & SONS INC
6 patentsUS5157027AOct 20, 1992
Bisphosphonate squalene synthetase inhibitors and method
SQUIBB & SONS INC152 citations98
US5106992AApr 21, 1992
3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
SQUIBB & SONS INC36 citations93
US4970221ANov 13, 1990
3,5-dihydroxypentanoic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
SQUIBB & SONS INC16 citations74
US5428028AJun 27, 1995
Method for lowering cholesterol employing a phosphonomethylphosphinate squalene synthetase inhibitor
SQUIBB & SONS INC4 citations63
US5103036AApr 7, 1992
Process for preparing 3-alkenylidene-1,1-bisphosphonates
SQUIBB & SONS INC5 citations63
US6087349AJul 11, 2000
Method for blocking neoplastic transformation of cells induced by ras oncogenes
SQUIBB & SONS INC2 citations60
(unassigned)
3 patentsUS5760246AJun 2, 1998
Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method
304 citations99
US5712396AJan 27, 1998
α-phosphonosulfonate squalene synthetase inhibitors
196 citations99
US5712261AJan 27, 1998
Method for preventing or treating hypertriglyceridemia
3 citations63